DTC
ENTA icon

Deep Track Capital’s Enanta Pharmaceuticals ENTA Stock Holding History

Deep Track Capital’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1M Sell
1,444,167
-512,700
-26% -$6.89M 0.31% 56
2026
Q1 		$24.7M Hold
1,956,867
– – 0.4% 49
2025
Q4 		$30.9M Buy
+1,956,867
New +$24.9M 0.55% 38
2022
Q2 		– Sell
-198,730
Closed -$14.1M – 54
2022
Q1 		$14.1M Buy
+198,730
New +$12.9M 0.91% 32

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deep Track Capital's ENTA Position: Q2 2026 in Review

Deep Track Capital reduced its Enanta Pharmaceuticals (ENTA) stake by 26% in Q2 2026, selling an estimated $6.89M and leaving 1,444,167 shares worth $21.1M. The position accounts for 0.31% of the portfolio, ranked #56.

Deep Track Capital first reported a position in ENTA in Q1 2022 and has held it in 4 quarters since. The position peaked at $30.9M in Q4 2025. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Deep Track Capital held 1,444,167 shares of Enanta Pharmaceuticals worth $21.1M as of Q2 2026.
  • Deep Track Capital sold 512,700 Enanta Pharmaceuticals shares in Q2 2026, an estimated $6.89M.
  • Enanta Pharmaceuticals made up 0.31% of Deep Track Capital's portfolio in Q2 2026, its #56 holding.
  • Deep Track Capital first reported a position in Enanta Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
  • Deep Track Capital's Enanta Pharmaceuticals position peaked at $30.9M in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.